Teva Expands Strategic Partnership with Veeva Systems
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 38 minutes ago
0mins
Source: PRnewswire
- Strategic Partnership Deepening: Teva Pharmaceuticals announced the global adoption of Veeva Vault CRM, further solidifying its strategic partnership with Veeva, aimed at enhancing customer success and commercial execution capabilities.
- Technological Foundation Enhancement: Vault CRM serves as the technological backbone for commercial processing, featuring the Agentic Call Report, which generates commercial evidence through compliant free text, thereby boosting Teva's market competitiveness in neuroscience and immunology.
- Customer-Centric Commitment: Teva is dedicated to meeting patient needs by providing complex generics and biosimilars, with Veeva's technological support facilitating its commercialization process in global markets and enhancing customer satisfaction.
- Industry Cloud Solutions: Veeva, as a cloud service provider for the life sciences sector, serves over 1,500 clients and is committed to innovation and product quality, further driving the digital transformation of the industry.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VEEV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VEEV
Wall Street analysts forecast VEEV stock price to rise
23 Analyst Rating
16 Buy
6 Hold
1 Sell
Moderate Buy
Current: 158.490
Low
222.00
Averages
317.10
High
380.00
Current: 158.490
Low
222.00
Averages
317.10
High
380.00
About VEEV
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. It offers span cloud software, data and business consulting and is designed to meet the needs of its customers and strategic business functions from research and development (R&D) through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. It owns Ostro, a brand engagement platform for life sciences that gives an artificial intelligence (AI)-driven chat experience.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Strategic Partnership Deepening: Teva Pharmaceuticals announced the global adoption of Veeva Vault CRM, further solidifying its strategic partnership with Veeva, aimed at enhancing customer success and commercial execution capabilities.
- Technological Foundation Enhancement: Vault CRM serves as the technological backbone for commercial processing, featuring the Agentic Call Report, which generates commercial evidence through compliant free text, thereby boosting Teva's market competitiveness in neuroscience and immunology.
- Customer-Centric Commitment: Teva is dedicated to meeting patient needs by providing complex generics and biosimilars, with Veeva's technological support facilitating its commercialization process in global markets and enhancing customer satisfaction.
- Industry Cloud Solutions: Veeva, as a cloud service provider for the life sciences sector, serves over 1,500 clients and is committed to innovation and product quality, further driving the digital transformation of the industry.
See More
- Digital Quality Vision: Kindeva partners with Veeva to adopt Veeva Quality Cloud, modernizing its manufacturing operations by unifying global sites onto a single cloud platform, thereby enhancing operational efficiency and supporting business growth.
- Compliance and Standardization: Veeva Quality Cloud will strengthen Kindeva's quality management infrastructure, ensuring compliance with global regulatory requirements, which will improve product quality and drive operational efficiency across the value chain.
- Data Integration and Collaboration: By connecting quality assurance and training, Kindeva can eliminate data silos, enhancing its ability to service clients and support growth across various regions and therapeutic areas.
- Productivity Enhancement: Veeva Quality Cloud will standardize quality processes, simplify systems infrastructure, and increase site productivity, creating greater value for the business, customers, and patients.
See More
- Quality Management Integration: Kindeva's adoption of Veeva Quality Cloud integrates its global manufacturing network onto a single cloud platform, enhancing operational efficiency and meeting growing customer demands.
- Real-Time Visibility Improvement: With Veeva QualityDocs and Veeva QMS, Kindeva achieves real-time operational visibility, enhancing its quality management infrastructure to ensure compliance with global regulatory requirements, thereby driving the large-scale delivery of high-quality products.
- Elimination of Data Silos: The new platform connects quality assurance and training, eliminating data silos and enabling Kindeva to service clients more efficiently while supporting growth across regions and therapeutic areas, thus enhancing overall business value.
- Global Standardization Procedures: Veeva Quality Cloud will facilitate the implementation of standardized global procedures, increasing site productivity and creating greater business value for Kindeva and its customers, helping the company stand out in a competitive market.
See More
- Quality Management Integration: Kindeva's adoption of Veeva Quality Cloud integrates its global manufacturing network onto a single cloud platform, thereby enhancing operational efficiency and meeting growing customer demands.
- Real-Time Visibility Improvement: With Veeva QualityDocs and Veeva QMS, Kindeva modernizes its quality management infrastructure, ensuring real-time visibility and efficient collaboration, which enhances the quality and speed of product delivery.
- Elimination of Data Silos: The new platform connects quality assurance with training, eliminating data silos and enabling Kindeva to better serve clients while supporting growth across various regions and therapeutic areas.
- Global Standardization Procedures: Veeva Quality Cloud allows Kindeva to implement standardized global procedures that increase site productivity, create greater business value, and ultimately deliver high-quality products to patients.
See More
- Global Partnership Agreement: Merck KGaA has committed to a global partnership with Veeva Systems, adopting Veeva Vault CRM to enhance its digital transformation, which is expected to significantly improve operational efficiency and customer service through better data connectivity and consistency.
- Digital Transformation Strategy: By integrating Veeva Vault, Merck KGaA's health division can achieve seamless data flow across different functions, thereby enhancing overall business flexibility to adapt to changing market demands.
- AI-Driven Efficiency Gains: The AI capabilities of Veeva Vault CRM will provide Merck KGaA with multiple intelligent agents aimed at boosting commercial efficiency and effectiveness, helping the company maintain a competitive edge in the fast-paced biopharmaceutical market.
- Customer-Centric Innovation: The implementation of Veeva Vault CRM will enable Merck KGaA to better meet customer needs by enhancing customer satisfaction and market share through integrated management capabilities and customer-oriented workflows.
See More
- Platform Launch: Veeva Systems has announced the launch of the Falcon platform, designed to enhance efficiency in drug development processes through standardized agents and workflows, which is expected to significantly reduce development costs for biopharmaceutical companies.
- Function Integration: Falcon seamlessly integrates with Veeva's clinical, regulatory, and safety applications, enabling faster document receipt and quality control processes, thereby improving compliance and accelerating time-to-market for drugs.
- Market Demand Response: Veeva anticipates that Falcon will be available to early users in November 2026, addressing the urgent need for automation and efficient processes in the biopharmaceutical industry, further solidifying its market leadership.
- Strategic Significance: As part of Veeva AI solutions, Falcon represents the company's commitment to innovation in drug development, aiming to drive overall industry efficiency through technological advancements.
See More











